Phathom Pharmaceuticals Inc (PHAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 28,519 | 29,664 | 16,352 | 7,324 | 1,912 |
| Cost of Goods | 3,724 | 3,815 | 2,356 | 1,376 | 426 |
| Gross Profit | 24,795 | 25,849 | 13,996 | 5,948 | 1,486 |
| Operating Expenses | 104,382 | 86,081 | 85,148 | 83,624 | 71,866 |
| Operating Income | -78,863 | -59,417 | -70,796 | -77,300 | -69,954 |
| Interest Expense | 18,071 | 18,593 | 18,484 | 17,764 | 17,168 |
| Other Income | 2,618 | 3,559 | 3,703 | 3,618 | 4,270 |
| Pre-tax Income | -94,316 | -74,451 | -85,577 | -91,446 | -82,852 |
| Net Income Continuous | -94,316 | -74,451 | -85,577 | -91,446 | -82,852 |
| Net Income | $-94,316 | $-74,451 | $-85,577 | $-91,446 | $-82,852 |
| EPS Basic Total Ops | -1.31 | -0.99 | -1.32 | -1.56 | -1.42 |
| EPS Basic Continuous Ops | -1.31 | -0.99 | -1.32 | -1.56 | -1.42 |
| EPS Diluted Total Ops | -1.31 | -0.99 | -1.32 | -1.56 | -1.42 |
| EPS Diluted Continuous Ops | -1.31 | -0.99 | -1.32 | -1.56 | -1.42 |
| EPS Diluted Before Non-Recurring Items | -1.15 | -0.88 | -1.32 | N/A | N/A |
| EBITDA(a) | $-77,990 | $-58,595 | $-70,016 | $-76,603 | $-69,266 |